Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2015. Start Trial.
Date Value
November 13, 2026 10.60
November 12, 2026 10.28
November 11, 2026 9.979
November 10, 2026 9.876
November 09, 2026 10.00
November 06, 2026 9.885
November 05, 2026 9.755
November 04, 2026 9.927
November 03, 2026 9.629
November 02, 2026 9.583
October 30, 2026 9.671
October 29, 2026 9.738
October 28, 2026 9.605
October 27, 2026 9.462
October 26, 2026 9.435
October 23, 2026 9.367
October 22, 2026 9.352
October 21, 2026 9.195
October 20, 2026 9.019
October 19, 2026 8.850
October 16, 2026 8.670
October 15, 2026 8.722
October 14, 2026 8.737
October 13, 2026 8.591
October 12, 2026 8.737
Date Value
October 09, 2026 8.823
October 08, 2026 8.571
October 07, 2026 8.791
October 06, 2026 8.700
October 05, 2026 8.776
October 02, 2026 8.770
October 01, 2026 8.749
September 30, 2026 8.769
September 29, 2026 9.12
September 28, 2026 9.199
September 25, 2026 9.021
September 24, 2026 9.225
September 23, 2026 8.922
September 22, 2026 9.500
September 21, 2026 9.501
September 18, 2026 9.466
September 17, 2026 9.559
September 16, 2026 9.904
September 15, 2026 9.588
September 14, 2026 10.59
September 11, 2026 10.54
September 10, 2026 10.45
September 09, 2026 10.43
September 08, 2026 10.80
September 04, 2026 10.82

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 1.772
Novo Nordisk A/S 5.561
Genmab A/S 4.988
Zealand Pharma A/S 0.9113
Evaxion AS 2.398

Price to Book Value Related Metrics